1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow FS 069: new trials by email Literature Review of FS 069 trials Research Report on FS 069
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Regadenoson Real Time Perfusion Imaging Trial-Optison Regadenoson; Optison - Coronary Artery Disease, Myocardial Perfusion Abnormalities | Phase 3 | Completed | University of Nebraska | 50 | 2012-07-31 | 2024-10-08 |
United States (1)